Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Rockville, Maryland
- Most recent report
- 8-K, filed Aug 3, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1356576
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 54
News 8 of 273
Prospectuses and Registrations 8
- S-8 Registration statement for an employee plan Jun 22, 2026
- S-8 POS Post-effective amendment to an employee plan registration Feb 24, 2025
- S-8 Registration statement for an employee plan Jun 17, 2024
- S-8 Registration statement for an employee plan Jun 25, 2021
- S-8 Registration statement for an employee plan Jun 26, 2020
- S-8 Registration statement for an employee plan Feb 17, 2017
- S-8 Registration statement for an employee plan Dec 18, 2014
- S-3 Shelf registration statement Dec 4, 2014
Proxies 8 of 24
- DEFA14A Extra proxy material Aug 3, 2026
- DEFA14A Extra proxy material Aug 3, 2026
- DEFA14A Extra proxy material Aug 3, 2026
- DEFA14A Extra proxy material Apr 30, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2026
- DEFA14A Extra proxy material Apr 30, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2025
- DEFA14A Extra proxy material Apr 29, 2024
Ownership 8 of 596
- 4 Insider reported a trade Aug 14, 2026
- 4 Insider reported a trade Aug 14, 2026
- 4 Insider reported a trade Aug 14, 2026
- 4 Insider reported a trade Aug 14, 2026
- 4 Insider reported a trade Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 6, 2026
- 4 Insider reported a trade Jul 31, 2026
- 4 Insider reported a trade Jul 31, 2026
Other 8 of 45
Everything here comes from Supernus Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.